As of April 17, 2026, Novavax's top three insider holders are John C Jacobs (President And Ceo, 225.68K shares), Elaine O'Hara (Evp, Chief Strategy Officer, 134.64K shares), James Patrick Kelly (Evp, Cfo And Treasurer, 130.60K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John C Jacobs | President And Ceo | 225,680 | 0 | 05 Mar, 2026 |
| Elaine O'Hara | Evp, Chief Strategy Officer | 134,642 | 0 | 05 Mar, 2026 |
| James Patrick Kelly | Evp, Cfo And Treasurer | 130,599 | 0 | 09 Mar, 2026 |
| Mark J Casey | Evp, Chief Legal Officer | 90,067 | 0 | 05 Mar, 2026 |
| John Trizzino | President And Coo | 68,061 | 0 | 11 Mar, 2025 |
| Filip Dubovsky | President, Rd | 66,613 | 0 | 20 Jun, 2024 |
| David M Mott | - | 60,890 | 0 | 13 Jun, 2025 |
| Richard Douglas | - | 54,340 | 0 | 13 Jun, 2025 |
| James F Young | - | 51,760 | 0 | 02 Jan, 2025 |
| Stanley C Erck | President And Ceo | 36,492 | 0 | 16 Dec, 2022 |
| Gregg H Alton | - | 28,805 | 0 | 16 Jun, 2025 |
| Richard J Rodgers | - | 28,490 | 0 | 30 Oct, 2025 |
| Margaret G Mcglynn | - | 25,588 | 0 | 16 Jun, 2025 |
| Rachel K. King | - | 25,190 | 0 | 13 Jun, 2025 |
| Ruxandra Draghia-Akli | Evp, Research Development | 23,563 | 0 | 04 Mar, 2026 |
| Gregory M Glenn | President, Rd | 18,339 | 0 | 14 Mar, 2023 |
| John A Iii Herrmann | Evp, Chief Legal Officer | 13,233 | 0 | 18 Dec, 2023 |
| Michael A Jr Mcmanus | - | 10,101 | 0 | 21 Jun, 2022 |
| John W. Shiver | - | 7,947 | 0 | 12 Mar, 2026 |
| John A Iii Herrmann | Evp, Chief Legal Officer | 0 | 3,384 | 28 Sep, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Mar, 2026 | John W. Shiver | Common Stock | A | 7,947 | $0.00 | 7,947 | D | M |
| 10 Mar, 2026 | John W. Shiver | Restricted Stock Units | D | 7,947 | $0.00 | 15,893 | D | M |
| 02 Mar, 2026 | Elaine O'Hara | 2026 Non-statutory Stock Option NQ | A | 177,500 | $0.00 | 177,500 | D | A |
| 02 Mar, 2026 | Ruxandra Draghia-Akli | Non-Statutory Stock Option NQ | A | 139,500 | $0.00 | 139,500 | D | A |
| 02 Mar, 2026 | Mark J Casey | Non-Statutory Stock Option NQ | A | 152,000 | $0.00 | 152,000 | D | A |
| 07 Mar, 2026 | James Patrick Kelly | Common Stock | A | 12,223 | $0.00 | 136,503 | D | M |
| 02 Mar, 2026 | James Patrick Kelly | Non-statutory Stock Option NQ | A | 194,000 | $0.00 | 194,000 | D | A |
| 02 Mar, 2026 | John C Jacobs | Non-Statutory Stock Option NQ | A | 551,500 | $0.00 | 551,500 | D | A |
| 07 Mar, 2026 | James Patrick Kelly | Common Stock | D | 5,904 | $9.98 | 130,599 | D | F |
| 07 Mar, 2026 | James Patrick Kelly | Restricted Stock Units | D | 12,223 | $0.00 | 0 | D | M |
| 03 Mar, 2026 | Elaine O'Hara | Common Stock | A | 56,334 | $0.00 | 157,071 | D | M |
| 03 Mar, 2026 | John C Jacobs | Common Stock | A | 150,167 | $0.00 | 264,130 | D | M |
| 03 Mar, 2026 | James Patrick Kelly | Common Stock | A | 43,167 | $0.00 | 145,130 | D | M |
| 03 Mar, 2026 | Mark J Casey | Common Stock | A | 37,500 | $0.00 | 101,445 | D | M |
| 03 Mar, 2026 | James Patrick Kelly | Common Stock | D | 20,850 | $9.49 | 124,280 | D | F |
| 03 Mar, 2026 | John C Jacobs | Common Stock | D | 69,288 | $9.49 | 225,680 | D | F |
| 03 Mar, 2026 | Elaine O'Hara | Common Stock | D | 22,429 | $9.49 | 134,642 | D | F |
| 03 Mar, 2026 | Mark J Casey | Common Stock | D | 11,378 | $9.49 | 90,067 | D | F |
| 03 Mar, 2026 | Elaine O'Hara | Restricted Stock Units | D | 56,334 | $0.00 | 112,666 | D | M |
| 03 Mar, 2026 | Mark J Casey | Restricted Stock Units | D | 4,000 | $0.00 | 4,000 | D | M |